A New Gene Coding for a Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1994 Jul 1

PMID 8006593

Citations 195

Authors

P G Coulie

V Brichard

A Van Pel

T Wolfel

J Schneider

C Traversari

S Mattei

E De Plaen

C Lurquin

J P Szikora

J C Renauld

T Boon

Affiliations

Soon will be listed here.

Abstract

It has been reported previously that antitumor cytolytic T lymphocyte (CTL) clones can be isolated from blood lymphocytes of HLA-A2 melanoma patients, after stimulation in vitro with autologous tumor cells, and that some of these CTL clones lyse most HLA-A2 melanomas. A first antigen recognized by such CTL clones was previously shown to be encoded by the tyrosinase gene. We report here the identification of another gene that also directs the expression of an antigen recognized on most melanomas by CTL clones that are restricted by HLA-A2. The gene, designated Melan-A, is unrelated to any known gene. It is 18 kb long and comprises five exons. Like the tyrosinase gene, it is expressed in most melanoma tumor samples and, among normal cells, only in melanocytes.

Citing Articles

[Immunohistochemical examinations in malignant melanoma : Fundamentals and special aspects].

Muller C Dermatologie (Heidelb). 2024; 75(12):947-966.

PMID: 39585407 DOI: 10.1007/s00105-024-05424-6.

Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.

Macandog A, Catozzi C, Capone M, Nabinejad A, Nanaware P, Liu S Cell Host Microbe. 2024; 32(11):2004-2018.e9.

PMID: 39481388 PMC: 11629153. DOI: 10.1016/j.chom.2024.10.006.

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.

Dong B, Obermajer N, Tsuji T, Matsuzaki J, Bonura C, Sander C Cancer Immunol Res. 2024; 12(10):1421-1437.

PMID: 38949179 PMC: 11706306. DOI: 10.1158/2326-6066.CIR-24-0061.

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TC2N.

Yang Z, Zhang H, Xia X, Zhang J Eur J Microbiol Immunol (Bp). 2024; 14(1):59-65.

PMID: 38358441 PMC: 10895358. DOI: 10.1556/1886.2024.00002.

Evaluating deep learning-based melanoma classification using immunohistochemistry and routine histology: A three center study.

Wies C, Schneider L, Haggenmuller S, Bucher T, Hobelsberger S, Heppt M PLoS One. 2024; 19(1):e0297146.

PMID: 38241314 PMC: 10798511. DOI: 10.1371/journal.pone.0297146.

References

Knuth A, Danowski B, Oettgen H, Old L . T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci U S A. 1984; 81(11):3511-5. PMC: 345538. DOI: 10.1073/pnas.81.11.3511. View

Herin M, Lemoine C, Weynants P, Vessiere F, Van Pel A, Knuth A . Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer. 1987; 39(3):390-6. DOI: 10.1002/ijc.2910390320. View

Seed B, Aruffo A . Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987; 84(10):3365-9. PMC: 304871. DOI: 10.1073/pnas.84.10.3365. View

De Plaen E, Lurquin C, Van Pel A, Mariame B, Szikora J, Wolfel T . Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. Proc Natl Acad Sci U S A. 1988; 85(7):2274-8. PMC: 279973. DOI: 10.1073/pnas.85.7.2274. View

Darrow T, Slingluff C, Seigler H . Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma. Cancer. 1988; 62(1):84-91. DOI: 10.1002/1097-0142(19880701)62:1<84::aid-cncr2820620116>3.0.co;2-r. View

Knuth A, Wolfel T, Klehmann E, Boon T, Meyer zum Buschenfelde K . Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci U S A. 1989; 86(8):2804-8. PMC: 287007. DOI: 10.1073/pnas.86.8.2804. View

Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N . Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 1992; 35(3):145-52. DOI: 10.1007/BF00185107. View

Mellon P, Parker V, Gluzman Y, Maniatis T . Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell. 1981; 27(2 Pt 1):279-88. DOI: 10.1016/0092-8674(81)90411-6. View

Mukherji B, Macalister T . Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med. 1983; 158(1):240-5. PMC: 2187080. DOI: 10.1084/jem.158.1.240. View

10.

Mattes M, Thomson T, Old L, LLOYD K . A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer. 1983; 32(6):717-21. DOI: 10.1002/ijc.2910320610. View

11.

Fossati G, Taramelli D, Balsari A, Bogdanovich G, Andreola S, Parmiani G . Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer. 1984; 33(5):591-7. DOI: 10.1002/ijc.2910330508. View

12.

Darrow T, Slingluff Jr C, Seigler H . The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol. 1989; 142(9):3329-35. View

13.

Wolfel T, Klehmann E, Muller C, Schutt K, Meyer zum Buschenfelde K, Knuth A . Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med. 1989; 170(3):797-810. PMC: 2189434. DOI: 10.1084/jem.170.3.797. View

14.

Vijayasaradhi S, Bouchard B, Houghton A . The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med. 1990; 171(4):1375-80. PMC: 2187848. DOI: 10.1084/jem.171.4.1375. View

15.

van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B . A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991; 254(5038):1643-7. DOI: 10.1126/science.1840703. View

16.

Kawakami Y, Zakut R, Topalian S, Stotter H, Rosenberg S . Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol. 1992; 148(2):638-43. View

17.

Karttunen J, Sanderson S, Shastri N . Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A. 1992; 89(13):6020-4. PMC: 402130. DOI: 10.1073/pnas.89.13.6020. View

18.

Brasseur F, Marchand M, Vanwijck R, Herin M, Lethe B, Chomez P . Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer. 1992; 52(5):839-41. DOI: 10.1002/ijc.2910520528. View

19.

Viret C, Davodeau F, Guilloux Y, Bignon J, Semana G, Breathnach R . Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Eur J Immunol. 1993; 23(1):141-6. DOI: 10.1002/eji.1830230123. View

20.

Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P . Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med. 1993; 177(4):989-98. PMC: 2190978. DOI: 10.1084/jem.177.4.989. View